ICAAC 2005

Pharmacokinetically Enhanced Amoxicillin and Clavulanate for Drug Resistant Streptococcus Pneumoniae

Thomas File
Thomas File

Thomas File, Summa Health System, Akron, Ohio
Community Associated Pneumonia is a sizeable problem for health systems, and what is more, some strains of the frequent culprit - streptococcus pneumoniae - are found to be drug resistant. Thomas File told the conference about a Pharmacokinetically Enhanced regimen of Amoxicillin and Clavulanate and how it does seem to be active in patients infected with one of these resistant strains.

Click here for all the interviews from ICAAC 2005

Similar Interviews

  • Audio Journal of Medicine: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco">Audio Journal of Medicine: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco
  • &t Jonathan Li

  • Pneumonia in Children Under One Year: Current Guidelines Not Sufficient
  • LISA McNALLY, Institute of Child Health, London, and University of KwaZulu-Natal, Durban REFERENCE: The Lancet 2007; 369:1440-1451 A new study suggests that current guidelines

  • BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns
  • Jennifer Lavrrar, Jane Hata, Jeanette Block REFERENCE: Slide Session C2-1360, 47th Annual Interscience Conference on Antimicrobial Agents

    Post a comment

    Subscribe to Audio Medica Podcast